A research collaboration to analyze the clinical factors that impact epilepsy care and outcomes was announced by the Department of Neurology at Emory University-School of Medicine and UCB SA. This work is part of an innovative research collaboration that seeks to identify factors and approaches that achieve optimal response in epilepsy patients. Epilepsy is a chronic neurological disorder defined as two or more unprovoked seizures. This collaboration, which is modeled after similar academia and industry drug discovery collaborations, focuses on real world disease and subsequent clinical and economic health outcomes. In the first project, investigators will use de-identified patient-level data from an administrative claims database to better understand characteristics of people living with epilepsy, including demographics. Dr. Helmers is joined by researchers Edward Faught, M.D., and David Thurman M.D., M.P.H., of the Emory University Department of Neurology. All represent Emory on the research collaboration's joint steering committee, which also includes three members from UCB representing corporate affairs, health economics and outcomes research, and medical affairs. The Rollins School of Public Health Biostatistics Consulting Center, which specializes in comprehensive statistical consultation and computational services, will support the investigators in their analysis.